Tag: nyse:azn

December 23, 2019

Pharma Trends 2019: FDA Approvals Make Waves Through Market

INN takes a look at the pharma trends of 2019 that have shaken up the space this year and created...
November 12, 2019

Aravive and AstreZeneca Begin Phase 1/2 Study of AVB-500

The Phase 1/2 clinical trial of AVB-500 is being done in combination with durvalumab in patients with ovarian cancer.
October 8, 2019

5 Top NASDAQ Pharma Stocks Year-to-Date

With Q4 in full swing, it's time to reflect on the top-performing NASDAQ pharma stocks year-to-date.
October 2, 2019

GlaxoSmithKline Files NDA for Inhaler to Treat Asthma

The company's inhaler therapy, Trelegy Ellipta, has already been approved in the US for chronic obstructive pulmonary disease.
August 29, 2019

AstraZeneca’s Lupus Drug Finally Meets Endpoints in Phase 3 Trial

The victory comes almost exactly a year after AstraZeneca's lupus treatment didn't meet its primary endpoints in a different trial.
July 10, 2019

Pharma Market Update: Q2 2019 in Review

With Q2 2019 officially over, the Investing News Network shares a pharma market update on the biggest news and trends...
July 4, 2019

5 Top Biotech Stocks by Market Cap

What are the biggest names in biotechnology? We count down the five top biotech stocks based on market cap and...